Latest stories on AQST
Aquestive Therapeutics, Inc. (AQST) files 8-K
SEC 8-K50 · neutralgeneral
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
Business Insider67 · bullishproduct/pr
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Business Insider56 · neutralgeneral
Aquestive Therapeutics, Inc. (AQST) files 8-K
SEC 8-K50 · neutralgeneral
Aquestive Therapeutics: Rating Downgrade Despite Probability Of Anaphylm Approval
Seeking Alpha34 · bearishgeneral
AQST Q1 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
Aquestive Therapeutics, Inc. (AQST) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Aquestive Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Aquestive Therapeutics Q1 Earnings Call Highlights
Yahoo Finance58 · neutralearnings
Aquestive Therapeutics GAAP EPS of -$0.07 beats by $0.07, revenue of $14.4M beats by $3.5M
Seeking Alpha63 · neutralearnings